Scopus Publication Detail
The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in Scopus. This abstract is what is used to create the fingerprint of the publication.
Extracellular β-nicotinamide adenine dinucleotide (β-NAD) promotes the endothelial cell barrier integrity via PKA- and EPAC1/Rac1-dependent actin cytoskeleton rearrangement
Nagavedi S. Umapathy; Evgeny A. Zemskov; Joyce Gonzales; Boris A. Gorshkov; Supriya Sridhar; Trinad Chakraborty; Rudolf Lucas; Alexander D. Verin (Profiled Authors: Joyce N Gonzales; Alexander Dmitriyevich Verin; Boris A Gorshkov; Rudolf Lucas; Evgeny Alexandrovich Zemskov)
Journal of Cellular Physiology. 2010;223(1):215-223.Abstract
Extracellular β-NAD is known to elevate intracellular levels of calcium ions, inositol 1,4,5-trisphate and cAMP. Recently, β-NAD was identified as an agonist for P2Y1 and P2Y11 purinergic receptors. Since β-NAD can be released extracellularly from endothelial cells (EC), we have proposed its involvement in the regulation of EC permeability. Here we show, for the first time, that endothelial integrity can be enhanced in EC endogenously expressing β-NAD-activated purinergic receptors upon β-NAD stimulation. Our data demonstrate that extracellular β-NAD increases the transendothelial electrical resistance (TER) of human pulmonary artery EC (HPAEC) monolayers in a concentration-dependent manner indicating endothelial barrier enhancement. Importantly, β-NAD significantly attenuated thrombin-induced EC permeability as well as the barrier-compromising effects of Gram-negative and Gram-positive bacterial toxins representing the barrier-protective function of β-NAD. Immunofluorescence microscopy reveals more pronounced staining of cell-cell junctional protein VE-cadherin at the cellular periphery signifying increased tightness of the cell-cell contacts after β-NAD stimulation. Interestingly, inhibitory analysis (pharmacological antagonists and receptor sequence specific siRNAs) indicates the participation of both P2Y1 and P2Y11 receptors in β-NAD-induced TER increase. β-NAD-treatment attenuates the lipopolysaccharide (LPS)-induced phosphorylation of myosin light chain (MLC) indicating its involvement in barrier protection. Our studies also show the involvement of cAMP-dependent protein kinase A and EPAC1 pathways as well as small GTPase Rac1 in β-NAD-induced EC barrier enhancement. With these results, we conclude that β-NAD regulates the pulmonary EC barrier integrity via small GTPase Rac1- and MLCP- dependent signaling pathways. © 2010 Wiley-Liss, Inc.
PMID: 20054824 PMCID: PMC2893378
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Feng Liu; Alexander D. Verin; Talai Borbiev; Joe G. N. GarciaAmerican Journal of Physiology - Lung Cellular and Molecular Physiology. 2001;280(6 24-6):L1309-L1317.
Irina Petrache; Alexander D. Verin; Michael T. Crow; Anna Birukova; Feng Liu; Joe G. N. GarciaAmerican Journal of Physiology - Lung Cellular and Molecular Physiology. 2001;280(6 24-6):L1168-L1178.
Anna A. Birukova; Feng Liu; Joe G. N. Garcia; Alexander D. VerinAmerican Journal of Physiology - Lung Cellular and Molecular Physiology. 2004;287(1 31-1):L86-L93.
Appears in this Document